Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065325
Status:
COMPLETED
Last Update Posted:
2015-02-24
First Post:
2003-07-21
Brief Title:
The Evaluation of the Efficacy and Tolerability of FASLODEX Fulvestrant and AROMASIN Exemestane in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
9238IL0048
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None